Review for "Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo‐controlled CARMELINA® trial"

Author(s):  
Richard Pratley
Sign in / Sign up

Export Citation Format

Share Document